| PERIOD ENDING | 28-Feb-09 | 29-Feb-08 | 28-Feb-07 | | Total Revenue | 53,893 | 61,454 | 30,087 | | Cost of Revenue | 31,241 | 20,933 | 7,902 | | | Gross Profit | 22,652 | 40,521 | 22,185 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 27,926 | 19,626 | 9,773 | | Non Recurring | 3,795 | (2) | (1,276) | | Others | 4,941 | 2,911 | 1,529 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (14,010) | 17,986 | 12,159 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 351 | 983 | 261 | | Earnings Before Interest And Taxes | (13,659) | 18,969 | 12,420 | | Interest Expense | 169 |
-
| 51 | | Income Before Tax | (13,828) | 18,969 | 12,369 | | Income Tax Expense | (3,806) | 6,660 | 4,948 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (10,022) | 12,309 | 7,421 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (10,022) | 12,309 | 7,421 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,022) | $12,309 | $7,421 |
|
1.52% Nasdaq 
0.01 (0.81%) 
Income Statement
